Back
Aurinia Pharmaceuticals 10K Form
Buy
79
AUPH
Aurinia Pharmaceuticals
Last Price:
8.88
Seasonality Move:
24.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2023-11-02 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2023-08-03 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2023-05-04 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2022-08-04 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
Receive AUPH News And Ratings
See the #1 stock for the next 7 days that we like better than AUPH
AUPH Financial Statistics
Sales & Book Value
| Annual Sales: | $175.51M |
|---|---|
| Cash Flow: | $16.9M |
| Price / Cash Flow: | 45.19 |
| Annual Sales: | $2.71 |
| Price / Book: | 3.27 |
Profitability
| EPS (TTM): | -0.14000 |
|---|---|
| Net Income (TTM): | $-22.55M |
| Gross Margin: | $161.37M |
| Return on Equity: | -5.99% |
| Return on Assets: | -4.19% |
Aurinia Pharmaceuticals Earnings Forecast
Key Aurinia Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 26 years for AUPH is 91.94%.
- The Selling, General & Administrative Expenses for AUPH have been equal to 111.12% of Gross Profit Margin.
- The Research & Development expenses have been 28.28% of Revenue.
- The Interest Expense is -3.56% of Operating Income.
- The Net Earning history of AUPH is -44.45% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Aurinia Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AUPH |
| CUSIP: | 05156V |
| Website: | auriniapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.6 |
| Quick Ratio: | 4.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 15.41 |
AUPH Technical Analysis vs Fundamental Analysis
Buy
79
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a Buy
The current Aurinia Pharmaceuticals [AUPH] share price is $8.86. The Score for AUPH is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.